Gain Therapeutics (GANX) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.19
-0.17
-0.15
-0.13

Details

Expected EPS
-0.1375
Actual EPS
-0.13
Surprise EPS
0.01
Surprise Percent
+5.45%

Description

⁨Gain Therapeutics⁩ (⁦GANX⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts